LEADER 02418nam 2200493Ia 450 001 9910818398603321 005 20200520144314.0 010 $a1-60876-345-5 035 $a(CKB)2670000000041771 035 $a(EBL)3018501 035 $a(SSID)ssj0000428798 035 $a(PQKBManifestationID)11323185 035 $a(PQKBTitleCode)TC0000428798 035 $a(PQKBWorkID)10425014 035 $a(PQKB)10059308 035 $a(MiAaPQ)EBC3018501 035 $a(EXLCZ)992670000000041771 100 $a20080804d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aStatins /$fGunnar N. Holmqvist (editor) 205 $a1st ed. 210 $aNew York $cNova Science Publishers$dc2008 215 $a1 online resource (219 p.) 300 $aDescription based upon print version of record. 311 $a1-60692-103-7 320 $aIncludes bibliographical references and index. 327 $aStatin therapy for coronary artery disease beyond lipid lowering effect / Teruo Inoue, Koichi Node -- Side effects of statins in monotherapy / Helmut Sinzinger, Bernhard A. Peskar -- Preliminary findings about the trends of the renal hemodynamics and the proxies of cardiovascular risk during a short course of atorvastatin therapy in essential hypertensives / Luigi Vernaglione -- Beneficial effects of addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions / Hetal D. Shah ... [et al.] -- Non-lipid lowering effects of statins / A. Schmidt -- Statins in the therapy of acute coronary syndrome / Petr Ostadal -- Beneficial effects of addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions / Hetal D. Shah ... [et al.] -- Bad HDL-C responders to statins / Dirk Devroey -- Beneficial effects of statins in systemic lupus erythematosus : molecular mechanism involved / Antonio G. Tristano. 606 $aStatins (Cardiovascular agents) 606 $aAnticholesteremic agents 615 0$aStatins (Cardiovascular agents) 615 0$aAnticholesteremic agents. 676 $a615/.718 701 $aHolmqvist$b Gunnar N$01629948 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818398603321 996 $aStatins$93967979 997 $aUNINA